GBM38 GBM Model

GBM38, a Patient-Derived Xenograft (PDX) model, offers a comprehensive view of brain cancer. Dive into research and treatment development with this invaluable tool for the scientific community. PDX models like GBM38 serve as essential platforms for preclinical drug discovery. By preserving the genetic and histological characteristics of the patient tumor, GBM38 enables researchers to test a wide range of drug candidates efficiently. This accelerates the development of targeted therapies, ultimately benefiting brain cancer patients.

Model Details

Cancer Location: Intracranial
Cancer Type: Brain Cancer
Model Name: GBM38
Mouse Strain: Nu/Nu
Treatment Data Available: Chemotherapy (Temozolomide)
WES: Yes
RNAseq: Yes
Methylation: Yes
PDX Treatment: Yes
Patient Treatment History: Yes

GBM38 Survival

Survival of orthotopic intracranial implanted  GBM38 in Nu/Nu mice  (n=5)

Request Additional GBM Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content